The collaboration will involve the permanent presence of a Farminerva S.r.l. section on the science park, and will join two other biotechnology companies present there (LayLine Genomics and BioLab). Effort will be dedicated to accelerating domestic and international partnerships to in-license or co-develop new intellectual property with the aim to move the development as far as possible up the biomedical product value chain, prior to out-licensing for significant value creations.
Fondazione Parco Biomedico San Raffaele (PSB)
Located approximately 15 km south of Rome in a natural reserve, the science park was created by the Banca di Roma, the Chamber of Commerce of Rome, and the Fondazione San Raffaele Monte Tabor in response to the recognised need to have a biomedical research centre in the Lazio region. Opened in 2002, the park is now home to 3 companies and 9 research groups from Universities and centres working in: Stem cells, Oncology, leukaemia and Immunology; Molecular cardiology; Skeletal regeneration; Cell therapy and tissue engineering; Muscular dystrophies; Biomedical quality control; Neurological Disorders and Diabetes. The infrastructure permits the development of concept to preclinical development based on the state-of-the-art facilities including a animal facility encompassing conventional and SPF small animals and a large animal surgery unit.
Farminerva is a private company, founded in 2006, focused on research activities to reach new advanced solutions in biomedical sector. These objectives are developed by a strong cooperation with academic and institutional centres, as the Fondazione Parco Biomedico San Raffaele and CRISC of the Rome University, where Farminerva sponsors the execution of all preclinical and clinical studies requested by local regulatory authorities to obtain marketing license.
This collaboration defines a platform which promotes and coordinates research projects from preclinical to clinical phases to improve specific knowledge in two particular field: the first one concerns new products useful in early diagnosis of orthopaedic, cardiovascular, bone tissue inflammatory and/or infective based diseases, diabetic and oncological diseases. Further effort will be targeted on developing drugs for treatment of infective, diabetic and oncological diseases.
The other one aims to discovery new therapeutic indication of generic drugs to treat neurological, psychiatric and abuse disorders (second/other medical use), through the participation of CNR IASI researchers which perform advanced statistical analysis on large database (1/3 million of subjects) to identify co-morbidity data of relevant clinic interest.
About 50 free lance professionals work in Farminerva projects to ensure high quality level in management and monitoring activities and significantly shorter time to achieve the marketing phase.
Jonathan Dando | alfa
Symbiotic bacteria: from hitchhiker to beetle bodyguard
28.04.2017 | Johannes Gutenberg-Universität Mainz
Nose2Brain – Better Therapy for Multiple Sclerosis
28.04.2017 | Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB
More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.
Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...
Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.
"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...
The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.
Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...
The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...
Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.
Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...
28.04.2017 | Event News
20.04.2017 | Event News
18.04.2017 | Event News
28.04.2017 | Medical Engineering
28.04.2017 | Earth Sciences
28.04.2017 | Life Sciences